InsmedMEX:INSM 67 Days Inventory is 254.76 as of Mar. 2026, which is 37% below its 10-year median of 406.66. GuruFocus rates MEX:INSM with a GF Score™ of 67/100 and a GF Value™ of MXN2,953.38 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 636 Biotechnology companies, Insmed ranks worse than 67.3% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Insmed's Average Total Inventories for the
three
months ended in Mar. 2026 was MXN2,387 Mil. Insmed's Cost of Goods Sold for the
three
months ended in Mar. 2026 was MXN855 Mil.
Hence, Insmed's Days Inventory for the
three
months ended in Mar. 2026 was 254.76.
The historical rank and industry rank for Insmed's Days Inventory or its related term are showing as below:
MEX:INSM'
s Days Inventory Range Over the Past 10 Years
Min: 266.42 Med: 406.66 Max: 1059.3
Current: 290.99
During the past 13 years, Insmed's highest Days Inventory was 1059.30. The lowest was 266.42. And the median was 406.66.
MEX:INSM's Days Inventory is ranked worse than 67.3% of 636
companies
in the Biotechnology industry
Industry Median: 183.195
vs MEX:INSM: 290.99
Insmed's Days Inventory
declined
from Mar. 2025 (431.43) to Mar. 2026 (254.76).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Insmed's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.36.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Insmed's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.43.
Insmed (MEX:INSM) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Insmed's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Insmed's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Insmed Days Inventory Related Terms
Insmed Days Inventory Historical Data
* Premium members only.
The historical data trend for Insmed's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:INSM vs INCY, BNTX, ROIV: Days Inventory Comparison
For the Biotechnology subindustry, Insmed's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Insmed Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Insmed's Days Inventory distribution charts can be found below:
* The bar in red indicates where Insmed's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Insmed (MEX:INSM) has a Days Inventory of 254.76 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Insmed and its competitors. This is 37% below median its historical median of 406.66. Over the past decade, Insmed's Days Inventory has ranged from 266.42 to 1,059.30. According to the industry distribution chart, Insmed ranks #428 out of 636 companies in the Biotechnology industry, placing it in the top 67.3%.
Is Insmed's Days Inventory too high?
Insmed's current Days Inventory of 254.76 is 37% below median its 10-year median of 406.66. Over the past 10 years, this metric has ranged from a low of 266.42 to a high of 1,059.30. The Biotechnology industry median Days Inventory is 183.20. Insmed's value of 254.76 is 39.1% above this industry median. Based on the distribution chart, Insmed ranks #428 out of 636 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Insmed has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Insmed's Days Inventory compare to INCY and BNTX?
According to the Biotechnology industry distribution chart, Insmed ranks #428 out of 636 companies for Days Inventory. This places Insmed in the lower half of its industry. The industry median Days Inventory is 183.20. Insmed's value of 254.76 is 39.1% above this benchmark. Historically, Insmed's own Days Inventory has ranged from 266.42 to 1,059.30 over the past decade. While the company's 10-year median is 406.66 vs. the industry median of 183.20, Insmed has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 636 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Insmed's current Days Inventory of 254.76 is 39.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Insmed and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Insmed's current Days Inventory is 254.76, which is 37% below median its own 10-year median of 406.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Insmed stock overvalued right now?
Based on GuruFocus' analysis, Insmed (MEX:INSM) is currently considered Possible Value Trap. The stock's GF Value™ is MXN2,953.38, compared to a current price of MXN1,981.33 — trading 32.9% below its estimated fair value. The current Days Inventory is 254.76, which is 37% below median its 10-year median of 406.66 and 39.1% above the Biotechnology industry median of 183.20. Insmed's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Insmed (MEX:INSM), the current Days Inventory is 254.76 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Insmed (MEX:INSM) Overvalued in 2026?
Based on GuruFocus' analysis, Insmed stock appears to be undervalued.
The current stock price of MXN1,981.33 is trading 32.9% below its estimated GF Value™ of MXN2,953.38.
GuruFocus considers Insmed to be Possible Value Trap.
Key valuation signals for MEX:INSM:
Days Inventory: 254.76 (37% below median its 10-year median of 406.66)
GF Value™: MXN2,953.38 vs. price of MXN1,981.33 (32.9% below fair value)
Industry Position: 39.1% above the Biotechnology median (#428 of 636)
No single metric tells the full story. See the MEX:INSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Insmed Inc is a biopharmaceutical company. Its commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare. The company's two commercial products, Arikayce and Brinsupri, are both part of the Respiratory therapeutic area. The firm's clinical-stage programs are TPIP, INS1148, brensocatib, and INS1201, focusing on different therapeutic areas. Additionally, Insmed's pre-clinical research programs encompass various technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. Geographically, the company generates maximum revenue from the United States from the sale of its commercial products.
67GF Score
Get the complete analysis for MEX:INSM
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:INSM has been successfully added to your 
